Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Acorda Therapeutics Inc. (ACOR)

10.28   -0.69 (-6.29%) 05-23 16:00
Open: 10.88 Pre. Close: 10.93
High: 11.15 Low: 10.105
Volume: 711,864 Market Cap: 495M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.982 - 11.045 11.045 - 11.102
Low: 9.964 - 10.028 10.028 - 10.087
Close: 10.186 - 10.291 10.291 - 10.385

Technical analysis

as of: 2019-05-23 4:23:07 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 13.04     One year: 14.19
Support: Support1: 9.58    Support2: 7.97
Resistance: Resistance1: 11.17    Resistance2: 12.15
Pivot: 11.27
Moving Average: MA(5): 10.79     MA(20): 11.12
MA(100): 13.74     MA(250): 19.37
MACD: MACD(12,26): -0.35     Signal(9): -0.34
Stochastic oscillator: %K(14,3): 38.39     %D(3): 46.91
RSI: RSI(14): 36.85
52-week: High: 36.35  Low: 9.58  Change(%): -56.3
Average Vol(K): 3-Month: 79551  10-Days: 69619

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ACOR has closed below the lower band by 3.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 29.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 19 May 2019 22:07:05 Z
Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 5/19/2019

Sat, 04 May 2019 22:08:23 Z
Acorda Therapeutics (ACOR) Q1 2019 Earnings Call Transcript

Thu, 02 May 2019 18:07:00 Z
Acorda (ACOR) Earnings and Revenues Beat Estimates in Q1

Thu, 02 May 2019 13:16:38 Z
Acorda Therapeutics (ACOR) Reports Q1 Loss, Tops Revenue Estimates

Thu, 25 Apr 2019 17:28:10 Z
Earnings Preview: Acorda Therapeutics (ACOR) Q1 Earnings Expected to Decline

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 48.10
Shares Float (M) 47.06
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 1.620
EPS Est. Current Year 1.750
EPS Est. Next Year 0.700
EPS Est. Next Quarter 0.860
Forward EPS -2.021
Book Value (p.s.) 0.980
PEG Ratio -0.11
Profit Margin -1.76
Operating Margin 12.74
Return on Assets (ttm) -0.5
Return on Equity (ttm) -1.1
Qtrly Rev. Growth -58.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 44.60
Levered Free Cash Flow (M) 6.39

Stock Valuations

P/E 6.35
P/E Growth Ratio -0.06
P/BV 10.49
P/S 57133532.00
P/CF 11.09

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.